I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| mast cell | 24 studies | 39% ± 17% | |
| CD8-positive, alpha-beta T cell | 19 studies | 25% ± 9% | |
| CD4-positive, alpha-beta T cell | 12 studies | 24% ± 7% | |
| T cell | 12 studies | 28% ± 10% | |
| platelet | 10 studies | 59% ± 13% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 9 studies | 20% ± 3% | |
| CD8-positive, alpha-beta memory T cell | 7 studies | 24% ± 4% | |
| effector memory CD8-positive, alpha-beta T cell | 7 studies | 22% ± 6% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 6 studies | 21% ± 5% | |
| mucosal invariant T cell | 6 studies | 21% ± 9% | |
| regulatory T cell | 6 studies | 21% ± 4% | |
| gamma-delta T cell | 6 studies | 26% ± 20% | |
| mature NK T cell | 5 studies | 17% ± 2% | |
| natural killer cell | 5 studies | 20% ± 3% | |
| megakaryocyte | 4 studies | 36% ± 22% | |
| effector CD8-positive, alpha-beta T cell | 4 studies | 23% ± 5% | |
| effector memory CD8-positive, alpha-beta T cell, terminally differentiated | 4 studies | 23% ± 6% | |
| CD4-positive, alpha-beta memory T cell | 4 studies | 21% ± 4% | |
| lymphocyte | 3 studies | 44% ± 15% |
